Launching! to Adulthood Program for Autism

Recruiting in Palo Alto (17 mi)

Overseen byAntonio Pagan, PhD

Age: 18 - 65

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: The University of Texas Health Science Center, Houston

No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to evaluate the effectiveness of the Launching intervention (Pagan et al., 2024) in improving adaptive functioning, transition readiness, and social cognition in young adults with Autism Spectrum Disorder (ASD), compared to a delayed treatment control group, to examine whether the Launching intervention leads to improvements in executive functioning, co-occurring mental health symptoms, and quality of life, as measured by caregiver and self-report assessments, to assess the maintenance of treatment gains 12 weeks post-treatment and to replicate the findings of the Launching pilot study in an independent sample of young adults with ASD.

Eligibility Criteria

This trial is for young adults with Autism Spectrum Disorder (ASD) who are transitioning to adulthood. It aims to help them improve their daily living skills, readiness for adult life, and social understanding. Participants must meet specific criteria related to ASD diagnosis and be able to attend group therapy sessions.

Inclusion Criteria

Confirmed case of ASD from a licensed mental health or medical professional

Meets DSM-5 criteria for ASD based on a Diagnostic and Statistical Manual of Mental Disorders (DSM-5) ASD symptom checklist

I am willing and motivated to undergo treatment.

See 3 more

Exclusion Criteria

I have a history of or currently experience severe mental health symptoms.

Suicidal ideation with intent or plan

Current alcohol or other substance use disorder rated severe

See 2 more

Treatment Details

Interventions

Launching! to adulthood program (Behavioral Intervention)

Trial OverviewThe study tests the 'Launching! to Adulthood' program against standard care in individuals with ASD. The program's effectiveness on adaptive functioning, transition readiness, social cognition, executive functioning, mental health symptoms, and quality of life will be measured through various assessments.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: Launching! to adulthood group therapyExperimental Treatment1 Intervention

Group II: No intervention then Launching! to adulthood group therapyActive Control2 Interventions